Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Douglas Bruce

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
The AIDS Reader|October 4, 2003
Editorial comment: why treat three conditions when it is one patient?R Douglas Bruce, Frederick L Altice
The International Journal on Drug Policy|January 30, 2008
Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detentionR Douglas Bruce, Rebecca A Schleifer
Infectious Disease Clinics of North America|May 16, 2007
Clinical care of the HIV-infected drug userR Douglas Bruce, Frederick L Altice
The American Journal of Medicine|October 26, 2013
The replyR Douglas Bruce, Leo Beletsky, Sharon Stancliff
Expert Opinion on Drug Metabolism & Toxicology|May 4, 2016
Drug interactions between buprenorphine, methadone and hepatitis C therapeuticsOnyema Ogbuagu, Gerald Friedland, R Douglas Bruce
AIDS (London, England)|November 15, 2005
Clinical management of depression and anxiety in HIV-infected adultsSanjay Basu, Lydia A Chwastiak, R Douglas Bruce
The American Journal of Drug and Alcohol Abuse|September 25, 2007
Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidenceMichael M Copenhaver, R Douglas Bruce, Frederick L Altice
The American Journal of Medicine|October 26, 2013
The replyR Douglas Bruce, Leo Beletsky, Sharon Stancliff, et al.
Expert Review of Clinical Pharmacology|January 14, 2014
Pharmacokinetic drug interactions between drugs of abuse and antiretroviral medications: implications and management for clinical practiceR Douglas Bruce, Frederick L Altice, Gerald H Friedland
Advances in Preventive Medicine|April 11, 2013
Evidence-based prevention interventions for people who use illicit drugsThomas F Kresina, R Douglas Bruce, Kevin P Mulvey
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
The AIDS Reader|October 4, 2003
Editorial comment: why treat three conditions when it is one patient?R Douglas Bruce, Frederick L Altice
The International Journal on Drug Policy|January 30, 2008
Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detentionR Douglas Bruce, Rebecca A Schleifer
Infectious Disease Clinics of North America|May 16, 2007
Clinical care of the HIV-infected drug userR Douglas Bruce, Frederick L Altice
The American Journal of Medicine|October 26, 2013
The replyR Douglas Bruce, Leo Beletsky, Sharon Stancliff
Expert Opinion on Drug Metabolism & Toxicology|May 4, 2016
Drug interactions between buprenorphine, methadone and hepatitis C therapeuticsOnyema Ogbuagu, Gerald Friedland, R Douglas Bruce
AIDS (London, England)|November 15, 2005
Clinical management of depression and anxiety in HIV-infected adultsSanjay Basu, Lydia A Chwastiak, R Douglas Bruce
The American Journal of Drug and Alcohol Abuse|September 25, 2007
Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidenceMichael M Copenhaver, R Douglas Bruce, Frederick L Altice
The American Journal of Medicine|October 26, 2013
The replyR Douglas Bruce, Leo Beletsky, Sharon Stancliff, et al.
Expert Review of Clinical Pharmacology|January 14, 2014
Pharmacokinetic drug interactions between drugs of abuse and antiretroviral medications: implications and management for clinical practiceR Douglas Bruce, Frederick L Altice, Gerald H Friedland
Advances in Preventive Medicine|April 11, 2013
Evidence-based prevention interventions for people who use illicit drugsThomas F Kresina, R Douglas Bruce, Kevin P Mulvey
Pageof 8